《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读

2023-03-21 四川省医学科学院 医药导报 发表于安徽省

该文对《他汀相关肌肉症状患者反安慰药效应的分步诊断与管理意见书》进行解读。

中文标题:

《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读

发布机构:

四川省医学科学院

发布日期:

2023-03-21

简要介绍:

2022年2月,国际血脂专家组(ILEP)发布《他汀相关肌肉症状患者反安慰药效应的分步诊断与管理意见书》。该意见书对他汀相关肌肉症状进行归因,并提出反安慰药效应(nocebo/drucebo效应)一词,用以形容患者因对他汀药物的不好预期而导致的不良反应,并针对此效应提出以患者为中心的分步诊断与管理措施,以期改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=577a21c0031e0a0a, title=《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读, enTitle=, guiderFrom=医药导报, authorId=0, author=, summary=该文对《他汀相关肌肉症状患者反安慰药效应的分步诊断与管理意见书》进行解读。, cover=https://img.medsci.cn/20230601/1685624594994_5579292.png, journalId=0, articlesId=null, associationId=2170, associationName=四川省医学科学院, associationIntro=四川省医学科学院, copyright=0, guiderPublishedTime=Tue Mar 21 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">2022年2月,国际血脂专家组(ILEP)发布《他汀相关肌肉症状患者反安慰药效应的分步诊断与管理意见书》。该意见书对他汀相关肌肉症状进行归因,并提出反安慰药效应(nocebo/drucebo效应)一词,用以形容患者因对他汀药物的不好预期而导致的不良反应,并针对此效应提出以患者为中心的分步诊断与管理措施,以期改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=124383, tagName=他汀相关肌肉症状)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=124383, articleKeyword=他汀相关肌肉症状, articleKeywordNum=6, guiderKeywordId=124383, guiderKeyword=他汀相关肌肉症状, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3984, appHits=64, showAppHits=0, pcHits=72, showPcHits=3920, likes=0, shares=418, comments=6, approvalStatus=1, publishedTime=Fri Jun 02 20:57:00 CST 2023, publishedTimeString=2023-03-21, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Jun 01 21:04:06 CST 2023, updatedBy=2427819, updatedName=梁丽玲, updatedTime=Tue Jan 02 09:20:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=安徽省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读.pdf)])
《2022国际血脂专家组意见书:他汀相关肌肉症状患者反安慰药效应的分步诊断与管理》解读.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2140578, encodeId=b70921405e8e1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:13:36 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140575, encodeId=b83c21405e5eb, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:46 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140574, encodeId=6f6f21405e4ce, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:38 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省)]
    2023-06-03 梅照东 来自山东省
  2. [GetPortalCommentsPageByObjectIdResponse(id=2140578, encodeId=b70921405e8e1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:13:36 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140575, encodeId=b83c21405e5eb, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:46 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140574, encodeId=6f6f21405e4ce, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:38 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省)]
    2023-06-03 梅照东 来自山东省

    改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2140578, encodeId=b70921405e8e1, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:13:36 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140575, encodeId=b83c21405e5eb, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:46 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2140574, encodeId=6f6f21405e4ce, content=改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ac884056742, createdName=梅照东, createdTime=Sat Jun 03 05:10:38 CST 2023, time=2023-06-03, status=1, ipAttribution=山东省)]
    2023-06-03 梅照东 来自山东省

    改善血脂异常人群接受降脂治疗的长期依从性,从而改善预后。该文对这一意见书进行解读。

    0